115 related articles for article (PubMed ID: 8419396)
1. Inhibitory effects of a bacteria-derived sulfated polysaccharide against basic fibroblast growth factor-induced endothelial cell growth and chemotaxis.
Nakayama Y; Iwahana M; Sakamoto N; Tanaka NG; Osada Y
J Cell Physiol; 1993 Jan; 154(1):1-6. PubMed ID: 8419396
[TBL] [Abstract][Full Text] [Related]
2. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
[TBL] [Abstract][Full Text] [Related]
3. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors.
Rusnati M; Urbinati C; Presta M
J Cell Physiol; 1993 Jan; 154(1):152-61. PubMed ID: 8419401
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB
J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854
[TBL] [Abstract][Full Text] [Related]
5. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
Foxall C; Wei Z; Schaefer ME; Casabonne M; Fugedi P; Peto C; Castellot JJ; Brandley BK
J Cell Physiol; 1996 Sep; 168(3):657-67. PubMed ID: 8816920
[TBL] [Abstract][Full Text] [Related]
6. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
7. Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.
Presta M; Rusnati M; Urbinati C; Sommer A; Ragnotti G
J Cell Physiol; 1991 Dec; 149(3):512-24. PubMed ID: 1660485
[TBL] [Abstract][Full Text] [Related]
8. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
Volin MV; Harlow LA; Woods JM; Campbell PL; Amin MA; Tokuhira M; Koch AE
Arthritis Rheum; 1999 Sep; 42(9):1927-35. PubMed ID: 10513809
[TBL] [Abstract][Full Text] [Related]
9. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
[TBL] [Abstract][Full Text] [Related]
10. Endothelial proteoglycans inhibit bFGF binding and mitogenesis.
Forsten KE; Courant NA; Nugent MA
J Cell Physiol; 1997 Aug; 172(2):209-20. PubMed ID: 9258342
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture.
Toda S; Nishimura T; Yamada S; Koike N; Yonemitsu N; Watanabe K; Matsumura S; Gärtner R; Sugihara H
J Pathol; 1999 Aug; 188(4):415-22. PubMed ID: 10440753
[TBL] [Abstract][Full Text] [Related]
12. Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans.
Reis RC; Schuppan D; Barreto AC; Bauer M; Bork JP; Hassler G; Coelho-Sampaio T
Biochem Biophys Res Commun; 2005 Aug; 333(3):976-83. PubMed ID: 15985216
[TBL] [Abstract][Full Text] [Related]
13. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.
Taraboletti G; Belotti D; Borsotti P; Vergani V; Rusnati M; Presta M; Giavazzi R
Cell Growth Differ; 1997 Apr; 8(4):471-9. PubMed ID: 9101093
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation.
Vogel T; Guo NH; Guy R; Drezlich N; Krutzsch HC; Blake DA; Panet A; Roberts DD
J Cell Biochem; 1994 Mar; 54(3):299-308. PubMed ID: 8200910
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factors released by wounded endothelial cells stimulate proliferation of synovial cells.
Eguchi K; Migita K; Nakashima M; Ida H; Terada K; Sakai M; Kawakami A; Aoyagi T; Ishimaru T; Nagataki S
J Rheumatol; 1992 Dec; 19(12):1925-32. PubMed ID: 1294742
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of bFGF/EGF-dependent endothelial cell proliferation by the hyaluronan-binding protease from human plasma.
Etscheid M; Beer N; Kress JA; Seitz R; Dodt J
Eur J Cell Biol; 2004 Jan; 82(12):597-604. PubMed ID: 15035435
[TBL] [Abstract][Full Text] [Related]
17. Quantitative characterization of high- and low-affinity binding sites for basic fibroblast growth factor on trabecular cells of the eye.
Tripathi RC; Borisuth NS; Li J; Tripathi AJ; Tripathi BJ
Exp Eye Res; 1997 Mar; 64(3):335-41. PubMed ID: 9196384
[TBL] [Abstract][Full Text] [Related]
18. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin.
Vogel T; Guo NH; Krutzsch HC; Blake DA; Hartman J; Mendelovitz S; Panet A; Roberts DD
J Cell Biochem; 1993 Sep; 53(1):74-84. PubMed ID: 8227183
[TBL] [Abstract][Full Text] [Related]
19. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the epidermal growth factor receptor by basic fibroblast growth factor.
Maher PA
J Cell Physiol; 1993 Feb; 154(2):350-8. PubMed ID: 8425916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
